2nd Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Firm
Client
Income
—
Expenses
$800,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act of 2017 (P.L. 115-97)

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Veterans VET

Education related to Hepatitis C. FY18/19 Military Construction VA Appropriations bill.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Health Issues HCR

Administration's "Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs"; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV and HIV portfolio. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. Support for H.R. 5353/S.2579 - Eliminating Opioid Related Infectious Diseases Act of 2018. FDA safety requirements.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
COOKAB HASHEMI —
DAVID PULLIAM —

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 5353 (115th), S. 2579 (115th)

Foreign Relations FOR

Issues related to pharmaceuticals access and international finance for health services.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Medicare/Medicaid MMM

HCV testing, screening and linkage to care programs. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicaid duplicate discounts.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
COOKAB HASHEMI —
DAVID PULLIAM —

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Indian/Native American Affairs IND

Education related to Hepatitis C in American Indian population.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Budget/Appropriations BUD

Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
COOKAB HASHEMI —
DAVID PULLIAM —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.